FREE Account Opening + No Clearing Fees
Loading...

Dev Labtech Venture IPO vs Infinium Pharmachem IPO

Comparision between Dev Labtech Venture IPO and Infinium Pharmachem IPO.

IPO Details

Dev Labtech Venture IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while Infinium Pharmachem IPO is a SME Fixed Price Issue proposed to list at NSE SME.

  Dev Labtech Venture IPO Infinium Pharmachem IPO
Logo Dev Labtech Venture IPO Logo Infinium Pharmachem IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Fixed Price Issue Fixed Price Issue
Listing At BSE SME NSE SME
Lead Managers Beeline Capital Advisors Pvt Ltd Swastika Investmart Ltd
Registrar Link Intime India Private Ltd Bigshare Services Pvt Ltd
Market Maker Sunflower Broking Private Limited Swastika Investmart Limited
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Dev Labtech Venture IPO is up to ₹11.22 Cr whereas the issue size of the Infinium Pharmachem IPO is up to ₹25.26 Cr. The final issue price of Dev Labtech Venture IPO is ₹51.00 per share and of Infinium Pharmachem IPO is ₹135.00 per share.

  Dev Labtech Venture IPO Infinium Pharmachem IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final) ₹51.00 per share ₹135.00 per share
Discount (Retail)
Discount (Employee) ₹13.50 per share
Market Lot Size 2000 shares 1000 shares
Fresh Issue Size 22,00,000 shares 18,75,000 shares
Fresh Issue Size (Amount) up to ₹11.22 Cr up to ₹25.26 Cr
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 22,00,000 shares 18,75,000 shares
Issue Size Total (Amount) up to ₹11.22 Cr up to ₹25.26 Cr

IPO Timetable

Dev Labtech Venture IPO opens on Mar 17, 2023, while Infinium Pharmachem IPO opens on Mar 31, 2023. The closing date of Dev Labtech Venture IPO and Infinium Pharmachem IPO is Mar 21, 2023, and Apr 05, 2023, respectively.

  Dev Labtech Venture IPO Infinium Pharmachem IPO
Anchor Bid Date
Issue Open Mar 17, 2023 Mar 31, 2023
Issue Close Mar 21, 2023 Apr 05, 2023
Basis Of Allotment (Tentative) Mar 24, 2023 Apr 11, 2023
Initiation of Refunds (Tentative) Mar 27, 2023 Apr 12, 2023
Credit of Share (Tentative) Mar 28, 2023 Apr 13, 2023
Listing date (Tentative) Mar 29, 2023 Apr 17, 2023
Anchor Lockin End date 1 Apr 23, 2023 May 11, 2023
Anchor Lockin End date 2 Jun 22, 2023 Jul 10, 2023

Financials

Dev Labtech Venture IPO P/E ratio is 32.9, as compared to Infinium Pharmachem IPO P/E ratio of 7.83.

  Dev Labtech Venture IPO Infinium Pharmachem IPO
Financial
Dev Labtech Venture Limited Financial Information (Restated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and SurplusTotal Borrowing
31-Mar-20711.231,178.850.04144.80123.84154.05
31-Mar-21713.731,228.113.65148.45127.50177.53
31-Mar-22888.242,698.0143.62192.0766.35122.58
30-Sep-221,166.65966.4364.12717.86232.17114.52
Amount in ₹ Lakhs
Infinium Pharmachem Private Limited Financial Information (Restated Consolidated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthTotal Borrowing
31-Mar-202,244.603,941.6493.40424.74566.17
31-Mar-213,418.277,115.37272.48702.32579.47
31-Mar-225,899.9510,005.25610.641,310.221,385.01
30-Sep-227,075.717,985.39551.011,855.771,614.71
Amount in ₹ Lakhs
Promoter Shareholding (Pre-Issue) 92.66% 100%
Promoter Shareholding (Post-Issue) 68.01% 73.05%
P/E Ratio 32.9 7.83
Market Cap ₹42.18 Cr. ₹93.93 Cr.
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Dev Labtech Venture IPO retail investors (RII) are offered 10,44,000 shares while in Infinium Pharmachem IPO retail investors are offered 10,44,000 shares. Qualified institutional buyers (QIB) are offered in Dev Labtech Venture IPO and 0 shares in Infinium Pharmachem IPO.

  Dev Labtech Venture IPO Infinium Pharmachem IPO
Anchor Investor Reserveration
Market Maker Reserveration 1,12,000 shares 94,000 shares
QIB 0 shares
NII 10,44,000 shares 9,37,500 shares
RII 10,44,000 shares 9,37,500 shares
Employee 0 shares
Others
Total 20,88,000 shares 18,75,000 shares

Bids Received (Subscription)

Dev Labtech Venture IPO subscribed 5.47x in total, whereas Infinium Pharmachem IPO subscribed 1.84x.

  Dev Labtech Venture IPO Infinium Pharmachem IPO
QIB (times)
NII (times) 2.65x 1.80x
Big NII (times)
Small NII (times)
RII (times) 8.24x 1.86x
Employee (times)
Other (times)
Total (times) 5.47x 1.84x

Comments

Add a public comment...